Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $9.7900 (-13.59%) ($9.7100 - $11.1200) on Mon. Aug. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.56% (three month average) | RSI | 35 | Latest Price | $9.7900(-13.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -6.3% a day on average for past five trading days. | Weekly Trend | AUTL declines -4.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) DRIV(15%) IBB(14%) BOTZ(13%) EWI(13%) IWC(13%) | Factors Impacting AUTL price | AUTL will decline at least -2.28% in a week (0% probabilities). VXX(-9%) VIXM(-8%) TLT(-7%) BWX(-3%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.28% (StdDev 4.56%) | Hourly BBV | 0 () | Intraday Trend | -11.4% | | | |
|
1 - 5 Day Possible Target | $-7.39(-175.49%) | Resistance Level | $14.22 | 5 Day Moving Average | $12.74(-23.16%) | 10 Day Moving Average | $13.79(-29.01%) | 20 Day Moving Average | $14.22(-31.15%) | To recent high | -59% | To recent low | 0% | Market Cap | $512m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |